Company Overview of PainReform Ltd.
PainReform Ltd., a pharmaceutical company, develops and licenses products for the treatment of pain in Israel and the United States. The company offers PRF-108, a ropivacaine sustained released formulation that provides a local block anesthetic for post-operative pain. It provides pain drugs to physicians and patients. The company was founded in 2007 and is based in Tel Aviv, Israel with additional offices in New Jersey.
40 Einstein Street
Ramat Aviv Tower
Tel Aviv, 69102
Founded in 2007
972 9 960 1914
972 3 760 4355
Key Executives for PainReform Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
|Antaki Center for Herbal Medicine Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact PainReform Ltd., please visit www.painreform.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.